Literature DB >> 24727092

MicroRNAs as regulators and mediators of c-MYC function.

Rene Jackstadt1, Heiko Hermeking2.   

Abstract

In the past ten years microRNAs (miRNAs) have been widely implicated as components of tumor suppressive and oncogenic pathways. Also the proto-typic oncogene c-MYC has been connected to miRNAs. The c-MYC gene is activated in approximately half of all tumors, and its product, the c-MYC transcription factor, regulates numerous processes e.g. cell cycle progression, metabolism, epithelial-mesenchymal transition (EMT), metastasis, stemness, and angiogenesis, thereby facilitating tumor initiation and progression. c-MYC target-genes, which mediate these functions of c-MYC, represent a complex network of protein- and non-coding RNAs, including numerous miRNAs. For example, c-MYC directly regulates expression of the miR-17-92 cluster, miR-34a, miR-15a/16-1 and miR-9. Moreover, the expression and activity of c-MYC itself are under the control of miRNAs. Here, we survey how these networks mediate and regulate c-MYC functions. In the future, miRNAs connected to c-MYC may be used for diagnostic and therapeutic approaches. This article is part of a Special Issue entitled: Myc proteins in cell biology and pathology.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; MYC; Oncogene; miRNA

Mesh:

Substances:

Year:  2014        PMID: 24727092     DOI: 10.1016/j.bbagrm.2014.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  54 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression.

Authors:  Beverly A Teicher; Eric Polley; Mark Kunkel; David Evans; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; John Connelly; Erik Harris; Anne Monks; Joel Morris
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

3.  Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Guang Zhang; Jingxin Li; Xianning Wu; Xiaoling Ma; Ge Shan; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

Review 4.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

5.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

6.  Resetting cancer stem cell regulatory nodes upon MYC inhibition.

Authors:  Silvia Galardi; Mauro Savino; Fiorella Scagnoli; Serena Pellegatta; Federica Pisati; Federico Zambelli; Barbara Illi; Daniela Annibali; Sara Beji; Elisa Orecchini; Maria Adele Alberelli; Clara Apicella; Rosaria Anna Fontanella; Alessandro Michienzi; Gaetano Finocchiaro; Maria Giulia Farace; Giulio Pavesi; Silvia Anna Ciafrè; Sergio Nasi
Journal:  EMBO Rep       Date:  2016-11-16       Impact factor: 8.807

7.  A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.

Authors:  C Chang; J Liu; W He; M Qu; X Huang; Y Deng; L Shen; X Zhao; H Guo; J Jiang; X Y Fu; R Huang; D Zhang; J Yan
Journal:  Oncogene       Date:  2017-10-02       Impact factor: 9.867

8.  The answer's in the tail: MYC mRNA has a metabolic sensor that supports cancer chemoresistance.

Authors:  Nadine Royla; Stefan Kempa
Journal:  Mol Cell Oncol       Date:  2017-07-05

9.  c-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, miRNAs and lincRNAs.

Authors:  Wen Luo; Jiahui Chen; Limin Li; Xueyi Ren; Tian Cheng; Shiyi Lu; Raman Akinyanju Lawal; Qinghua Nie; Xiquan Zhang; Olivier Hanotte
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

Review 10.  MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.

Authors:  E Hessmann; G Schneider; V Ellenrieder; J T Siveke
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.